Sixty folks were laid off... Research and development was hit hard... This will sure give the company a temporary bump in profits, but it will cost us dearly in the long run... Get rid of experienced and knowledgeable folks so you can add more... — read more
half of clinical study department gone
seems the company gives up for new drug development, just focus on manufacturer.
Doing good
Doing good
monoclonal antibodies used to be all the rage a while ago
monoclonal antibodies used to be all the rage a while ago. that's not the case any more.